We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+11.93%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$470M
AUM Growth
+$29.3M
Cap. Flow
-$17.8M
Cap. Flow %
-3.78%
Top 10 Hldgs %
73.69%
Holding
76
New
3
Increased
26
Reduced
21
Closed
8

Top Buys

Rank Stock Value
1
FTGC icon
First Trust Global Tactical Commodity Strategy Fund
FTGC
+$4.72M
2
VGK icon
Vanguard FTSE Europe ETF
VGK
+$4.01M
3
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$3.34M
4
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$2.89M
5
DBC icon
Invesco DB Commodity Index Tracking Fund
DBC
+$916K

Top Sells

Rank Stock Value
1
EZU icon
iShare MSCI Eurozone ETF
EZU
+$2.93M
2
CFN
CAREFUSION CORPORATION
CFN
+$2.24M
3
HALO icon
Halozyme
HALO
+$1.94M
4
RGLS
Regulus Therapeutics
RGLS
+$1.28M
5
AMLP icon
Alerian MLP ETF
AMLP
+$1.21M

Sector Composition

Rank Sector Weight
1 Miscellaneous 97.16%
2 Healthcare 1.75%
3 Real Estate 0.45%
4 Consumer Staples 0.2%
5 Materials 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBFI
51
DELISTED
MB Financial Corp
MBFI
$492K 0.1%
15,705
– –
BDX icon
52
Becton Dickinson
BDX
$51.6B
$420K 0.09%
+3,000
New +$420K
AAPL icon
53
Apple
AAPL
$4.67T
$377K 0.08%
12,124
-7,220
-37% -$218K
SPY icon
54
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$368K 0.08%
1,784
-176
-9% -$36.3K
ACAD icon
55
Acadia Pharmaceuticals
ACAD
$5.02B
$326K 0.07%
10,000
– –
VDE icon
56
Vanguard Energy ETF
VDE
$10.7B
$320K 0.07%
2,930
– –
ILMN icon
57
Illumina
ILMN
$32.6B
$296K 0.06%
1,637
– –
DLN icon
58
WisdomTree US LargeCap Dividend Fund
DLN
$6.35B
$276K 0.06%
7,520
– –
SRE icon
59
Sempra
SRE
$55.1B
$265K 0.06%
4,860
+1,164
+31% +$64.1K
TSLA icon
60
Tesla
TSLA
$1.38T
$254K 0.05%
20,145
– –
EFA icon
61
iShares MSCI EAFE ETF
EFA
$79.6B
$236K 0.05%
3,676
+11
+0.3% +$693
ASRT
62
DELISTED
Assertio
ASRT
$224K 0.05%
167
– –
IVV icon
63
iShares Core S&P 500 ETF
IVV
$898B
$212K 0.05%
1,020
– –
IMUC
64
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$157K 0.03%
8,098
-1,750
-18% -$43.9K
SEEL
65
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
BIOC
66
DELISTED
Biocept, Inc.
BIOC
$38K 0.01%
+1
New +$67.2K
HEPA
67
DELISTED
Hepion Pharmaceuticals
HEPA
– –
0
– –
AMLP icon
68
Alerian MLP ETF
AMLP
$13.4B
– –
-13,772
Closed -$1.21M
EZU icon
69
iShare MSCI Eurozone ETF
EZU
$9.87B
– –
-80,620
Closed -$2.93M
GILD icon
70
Gilead Sciences
GILD
$181B
– –
-2,948
Closed -$278K
RGLS
71
DELISTED
Regulus Therapeutics
RGLS
– –
-667
Closed -$1.28M
CUDA
72
DELISTED
Barracuda Networks, Inc.
CUDA
– –
-13,750
Closed -$493K
IPCM
73
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
– –
-8,293
Closed -$381K
CFN
74
DELISTED
CAREFUSION CORPORATION
CFN
– –
-37,677
Closed -$2.24M
1 2
3

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Callan Capital held 76 positions worth $470M, up 6.7% from $441M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Callan Capital withdrew a net $17.8M in Q1 2015, closing 8 positions and reducing 21 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $2.93M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, up from 96% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Callan Capital opened a new position in Invesco DB Commodity Index Tracking Fund worth $888K.

  • Callan Capital's largest Q1 2015 buy was Invesco DB Commodity Index Tracking Fund: 52,021 shares worth $888K.
  • Callan Capital added most to First Trust Global Tactical Commodity Strategy Fund in Q1 2015, an estimated $4.72M increase.
  • Callan Capital's biggest Q1 2015 reduction was Halozyme, cutting an estimated $1.94M.
  • Callan Capital fully exited iShare MSCI Eurozone ETF in Q1 2015, selling an estimated $2.93M.
  • Callan Capital's ten largest holdings make up 74% of its $470M portfolio in Q1 2015.
  • Callan Capital opened 3 new positions and closed 8 in Q1 2015.
  • Callan Capital's portfolio value rose 6.7% quarter-over-quarter to $470M.

Based on Callan Capital's 13F filing for Q1 2015, filed 11 May 2015.